Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities.

Although the mutually exclusive of Cluster1 and Cluster2 mutations tend to be extremely significant, there are a still mall proportion of cases harboring both Cluster1 and Cluster2 mutations (31/1481, 2.1%).

also in 7,787 other papers